INTELLECTUAL PROPERTY & ASSET PURCHASE AGREEMENTIntellectual Property & Asset Purchase Agreement • October 9th, 2020 • Vivos Therapeutics, Inc. • Surgical & medical instruments & apparatus • Colorado
This INTELLECTUAL PROPERTY & ASSET PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of the 4th day of May 2017 (the “Effective Date”) by and between VIVOS BIOTECHNOLOGIES, INC. (the “Buyer”), a Wyoming corporation and Dr. Gurdev Dave Singh (the “Seller”).
INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENT dated as of March 17, 2015 by and between CHRISTOPHER O’BRIEN and NUGENE BIOPHARMA, INC. INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENTIntellectual Property Asset Purchase Agreement • May 5th, 2020 • California
THIS ASSET PURCHASE AGREEMENT, is made as of this March 17, 2015 by and among Chris O’Brien, an individual (“O’Brien”), and NuGene BioPharma, Inc., a California corporation (“Purchaser”).
Intellectual Property Asset Purchase AgreementIntellectual Property Asset Purchase Agreement • February 21st, 2023 • Mainz Biomed N.V. • Pharmaceutical preparations
BETWEEN: MAINZ BIOMED N.V., a corporate body incorporated in Amsterdam, with its principal place of business located at Sirius Gutenberg Park Robert-Koch-Straße 50, 55129, Mainz, Germany;
INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENTIntellectual Property Asset Purchase Agreement • September 6th, 2018 • Delaware
WHEREAS, on February 4, 2018, Sellers and its Subsidiaries (collectively, the “Debtors”) commenced ten voluntary chapter 11 bankruptcy cases (the “Bankruptcy Cases”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”);
INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENT by and among Novo Integrated Sciences, Inc. and 2731861 Ontario Corp.Intellectual Property Asset Purchase Agreement • December 23rd, 2019 • Novo Integrated Sciences, Inc. • Engines & turbines • Nevada
This Intellectual Property Asset Purchase Agreement (this “Agreement”) is entered into as of the date first set forth above (the “Effective Date”) by and between Novo Integrated Sciences, Inc., a Nevada corporation (the “Purchaser”) and 2731861 Ontario Corp., an Ontario, Canada corporation (“Seller”). Each of the Purchaser and Seller may be referred to herein collectively as the “Parties” and separately as a “Party.”
INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENTIntellectual Property Asset Purchase Agreement • June 3rd, 2020 • Clinigence Holdings, Inc. • Services-business services, nec • Delaware
This INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENT (“Agreement”), is made as of May 27, 2020 (the “Signing Date”) by and among Clinigence Health, Inc., a Delaware corporation (“Clinigence” or “Seller”), Clinigence Holdings, Inc., a Delaware corporation (“CLNH” or “Shareholder”), AHA Analytics, Inc., a Delaware corporation (“Purchaser”) and Accountable Healthcare America Inc., a Delaware corporation (“AHA” ).
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. INTELLECTUAL PROPERTY ASSET...Intellectual Property Asset Purchase Agreement • July 20th, 2020 • Inozyme Pharma, Inc. • Pharmaceutical preparations • Delaware
THIS INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of July 17, 2020 (the “Effective Date”) by and between Inozyme Pharma, Inc., a Delaware corporation with its principal office at 321 Summer Street, Floor 4, Boston, MA 02210 (the “Buyer”), on the one hand, and Alexion Pharmaceuticals, Inc., a Delaware corporation, with its principal office at 121 Seaport Boulevard, Boston, MA 02210 (the “Seller”, with Seller and Buyer each, individually, a “Party” and, collectively, the “Parties”), on the other hand.
INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENTIntellectual Property Asset Purchase Agreement • July 26th, 2021 • Gatc Health Corp • Services-health services • California
This Intellectual Property Asset Purchase Agreement (the “Agreement”), is made as of July 24, 2020 by and among GATC Canna, Inc. and GATC Rx, Inc., both California corporations having their principal place of business at 6 Upper Newport Plaza Drive, Newport Beach, CA 92660 (collectively, the “Purchaser” or “GATC”), and Frelii, Inc., a Nevada corporation with a principal place of business at 670 W. Shepard Lane, Suite 200, Farmington, UT 84025 (the “Seller” or “Frelii”). Purchaser and Seller are also referred to herein collectively as the “Parties” and individually as a “Party.”
INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENTIntellectual Property Asset Purchase Agreement • March 3rd, 2020 • Ontario
effective as of the • day of December, 2019 (“Effective Date”) by and between MOUNTAIN VALLEY MD INC., (“Purchaser”), an Ontario corporation with its registered office at 210 Adelaide Street West, Toronto, ON M5H
INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENTIntellectual Property Asset Purchase Agreement • March 12th, 2021 • Delaware
THIS INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of __________, 2018, by and between __________, a __________ (“Buyer”), The Bon-Ton Stores, Inc., a Delaware corporation (the “Company”), and each of the Company’s Subsidiaries listed on the signature page hereto (together with the Company, “Sellers”). Capitalized terms used herein and not otherwise defined herein have the meaning set forth in Article I.
INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENTIntellectual Property Asset Purchase Agreement • March 15th, 2022
This Amendment No. 1 (this “Amendment”), to that Intellectual Property Asset Purchase Agreement dated January 10, 2022 (the “Agreement”) between Pangenomic Health Inc. and LivNao Technologies Corp. (collectively, the “Parties”), is entered as of February 15, 2022 (the “Effective Date”).
INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENT DATED AS OF ____________, 2016 BY AND AMONG AND [NERF, INC.] AND THE OTHER PARTIES SIGNATORY HERETOIntellectual Property Asset Purchase Agreement • April 23rd, 2021 • Delaware
